TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.37
Delayed Data
As of Apr 01
 +0.32 / +5.29%
Today’s Change
3.42
Today|||52-Week Range
6.75
+43.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues2.8M3.8M4.2M4.3M
 
 
 
 
 
Cost of Goods Sold830.7K893.0K1.1M879.5K
 
 
 
 
 
Depreciation And Amortization13.1K14.1K12.7K12.6K
 
 
 
 
 
 
Operating ExpensesGross Income2.0M2.8M3.1M3.4M
 
 
 
 
 
General Expenses10.9M13.8M21.0M19.7M
 
 
 
 
 
Research And Development5.9M8.2M14.9M14.2M
 
 
 
 
 
Total Operating Expenses11.8M14.7M22.0M20.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.0M-10.9M-17.8M-16.3M
 
 
 
 
 
Interest Expense On Debt260.0K0.000.000.00
 
 
Other Expenses18.6K18.6K6.3K3.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.2M-10.9M-17.8M-16.3M
 
 
 
 
 
Net Income-9.2M-10.9M-17.8M-16.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS145.0M145.5M152.2M156.1M
 
 
 
 
 
Shares To Calculate EPS Diluted145.0M145.5M152.2M156.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.07-$0.12-$0.10
 
 
 
 
 
EPS Diluted-$0.06-$0.07-$0.12-$0.10
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account